Search bioRxiv⌕ Search
Home/Archive/bioRxiv

bioRxiv · 10.64898/2026.01.27.702179

Dietary cholesterol reduces blood pressure and alters lipid profiles in stroke-prone spontaneously hypertensive rats

Tatematsu, K.·Nishikata, Y.·Saito, Y.·Matsunaga, T.·Ohara, N.
View original source ↗Export metadata ↓

Abstract

Although cholesterol (Chol) is widely recognized as a risk factor for cardiovascular disease, dietary Chol intake has been reported to extend the lifespan of stroke-prone spontaneously hypertensive rats (SHRSP). The mechanisms responsible for this paradoxical effect remain unclear. The present study examined changes in organ lipid profiles and associated molecular factors in SHRSP rats fed a Chol-enriched diet. Four-week-old male SHRSP/Izm rats were assigned to three groups and fed ad libitum for 12 weeks with either a control diet (Ctr), a diet supplemented with 1% w/w Chol (Chol), or a diet containing 1% w/w Chol plus 0.025% w/w lovastatin (Stt) to suppress endogenous Chol synthesis. Systolic blood pressure was measured before and after the feeding period, and tissues were collected for analyses of sterol content, fatty acid composition, prostaglandin E2 (PGE2) levels, and renal histopathology. Relative to the Ctr group, the Chol group exhibited a significant 9-10% reduction in systolic blood pressure. This reduction was accompanied by pronounced alterations in lipid profiles, including changes in phytosterol content and decreased arachidonic acid ratios in serum and kidney. There was a downward trend in hepatic PGE2 levels, and a similar tendency was observed in the kidney. Comparable changes in lipid profiles were observed in the Stt group. Histological analysis revealed modest attenuation of renal pathological features in Chol-fed rats. This study demonstrates for the first time that dietary Chol reduces renal phytosterol accumulation and suppresses the AA-PGE2 axis, changes that coincide with a 9-10% reduction in systolic blood pressure and attenuated glomerular inflammation. These integrated findings provide a mechanistic framework linking dietary Chol to the previously reported lifespan extension in this stroke-prone model. Although these changes may contribute to improved renal pathology, further studies are required to clarify causal relationships.

Source connections

Explore related subjects

biochemistryPreprint

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Tatematsu, K., Nishikata, Y., Saito, Y., Matsunaga, T., Ohara, N.. 2026-01-30. Dietary cholesterol reduces blood pressure and alters lipid profiles in stroke-prone spontaneously hypertensive rats. https://doi.org/10.64898/2026.01.27.702179

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

bioRxiv2026

Biochemical reassessment of the activation of PANK1 by SGLT2 inhibitors

Although SGLT2 inhibitors (SGLT2i) show cardiovascular benefits in addition to glycemic control, their molecular target for cardiovascular effect remains unclear. A recent study reported that two SGLT2i, empagliflozin and dapagliflozin, directly activate pantothenate kinase 1 (PANK1), which mediate their cardioprotective effect. PANK1 phosphorylates pantothenate with ATP to yield 4'-phosphopantothenate and ADP, representing the rate-limiting enzyme of coenzyme A (CoA) biosynthesis. We therefore reassessed this claim using purified recombinant human PANK1. The malachite green assay detected free inorganic phosphate (Pi) but neither ADP nor 4'-phosphopantothenate and its signals do not reflect PANK1 activity. In the ADP-Glo assay, empagliflozin and dapagliflozin did not stimulate PANK1 under either basal conditions or acetyl-CoA feedback inhibition, while the activator PZ-2891 enhanced the activity of PANK1. These results show that SGLT2i do not directly activate PANK1, challenging the proposed PANK1-dependent cardioprotection mechanism.

biochemistry↗
bioRxiv2026

Intraspecific glucosinolate chemodiversity in Cardamine hirsuta

Within some plant species, a high intraspecific chemical variation, termed chemodiversity, can be found in the composition of specialized metabolites. For Brassicales, glucosinolates are highly characteristic. Their composition is genetically determined but variation has been found within species and between organs in different species. Cardamine hirsuta is increasingly being used as genetic model species, but until now, little was known about its genetically-based variation in glucosinolates. Thus, we aimed to characterize glucosinolate profiles, their putative genetic variation and their chemodiversity in established accessions and wild-collected material. We analyzed the glucosinolate profiles of leaves and roots from offspring, grown under standardized conditions, of 18 accessions collected in nine countries. Glucosinolates were quantified by HPLC-DAD and identities were confirmed by UHPLC-QToF-MS/MS. Glucosinolate composition was analyzed in biosynthetic terms, compared across samples with principal component analysis and chemodiversity was quantified as glucosinolate richness and Shannon diversity. In total, 14 glucosinolates were confirmed across samples. Two main sources of variation among accessions were the relative levels of but-3-enyl- versus pent-4-enylglucosinolate and of benzylglucosinolate versus phenethylglucosinolate. An almost universal presence of 1-methoxyindol-3-ylmethylglucosinolate in roots but not leaves was observed, along with quantitative contrasts between leaves and roots. The glucosinolate composition varied profoundly among accessions and between leaves and roots, while offspring within accessions were mostly consistent in their profiles. Even accessions collected in close proximity produced distinct profiles, with no clear separation along latitude or longitude. Our study highlights two independent and chemically simple traits of apparently genetic nature, namely the extent of chain elongation of methionine-derived and of phenylalanine-derived glucosinolates. Their independent occurrence is a main factor shaping the glucosinolate profiles among accessions. High variation was also observed at a local scale, highlighting complex genetic variation in glucosinolate biosynthesis in the species throughout Europe. Moreover, within individuals different organs showed clearly distinct profiles, indicating organ-specific biosynthesis. The genetic basis and ecological consequences of this variation need to be explored in future studies.

biochemistry↗
bioRxiv2026

Expanding Plasma Proteome Coverage While Preserving Biological Signatures: A Systematic Characterization of Enrichment and Preanalytical Variables

Plasma is a rich and accessible source for biomarkers. The analytical challenge of the steep dynamic range was recently addressed using enrichment technologies. Enrichment technologies have been shown to be sensitive to preanalytical variables, making this an active area of research. We established the P2 enrichment system as high-performing and robust for large scale studies, with reproducible identifications and precision across batches, days, operators and laboratories. We characterized P2-based enrichment for preanalytical variables (eight blood collection types, centrifugation, freeze-thaw and pathogen inactivation). K2EDTA-plasma resulted in the deepest proteome coverage with about 6000 protein groups on the timsTOF HT. We spiked 16 heavy-labelled proteins into platelet-poor and platelet-contaminated plasma. Importantly, linearity, accuracy, and precision were high in both platelet-poor and platelet-contaminated plasma for both P2-enriched and neat preparations. In a cancer cohort, we demonstrated that 97% of differentially abundant proteins retained the same direction of regulation after P2-based enrichment compared with the neat preparation. Differentially abundant proteins identified in a colorectal cancer pilot cohort remained largely conserved after platelet contamination, including previously reported biomarkers. We demonstrated that P2-based enrichment enables deep, large scale proteome profiling and preserves biological information despite preanalytical variation. Candidates emerging from P2-based discovery can be validated in independent cohorts with targeted assays.

biochemistry↗